IART: Integra LifeSciences Holdings Company Profile & Statistics

Integra LifeSciences Holdings Profile

About

Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products.

Info & Links

CEO

Mojdeh Poul

Headquarters

1100 CAMPUS ROAD
PRINCETON, NJ 08540, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

753

Employees

4,396

Integra LifeSciences Holdings Statistics

Valuation Measures

Market Capitalization²

1.10B

Enterprise Value

2.73B

Enterprise Value/EBITDA(ttm)

-7.88

Price to Earnings Ratio(ttm)

6.08

Price to Sales(ttm)

0.65

Price to Book(mrq)

1.02

Price to Cash(ytd)

3.06

Profitability

Gross Margin(ttm)

52.51%

Operating Margin(ttm)

10.55%

Profit Margin(ttm)

-30.38%

Return on Equity(ttm)

12.15%

Return on Invested Capital(ttm)

-21.97%

Return on Assets(ttm)

4.32%

Income Statement

Revenue(ttm)

1.62B

Revenue Per Share(ttm)

20.82

Gross Profit(ttm)

853.07M

EBITDA(ttm)³

-346.25M

Net Income Available to Common(ttm)

-500.63M

Diluted EPS(ttm)

-6.53

Share Statistics

Beta (5Y Monthly)

1.21

52-Week Change

-26.09%

S&P 500 52-Week Change

14.18%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

77.91M

Dividend Yield

0.00%

Float⁴

75.15M

% Held by Insiders

3.54%

% Held by Institutions

84.78%

Balance Sheet

Total Cash(mrq)

253.61M

Total Cash Per Share(mrq)

3.26

Total Debt(mrq)

1.84B

Total Debt/Equity(mrq)

177.18%

Current Ratio(mrq)

1.23%

Quick Ratio(mrq)

0.73%

Book Value Per Share(mrq)

13.33

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.03

Free Cash Flow(ytd)

-51.40M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

IART

Integra LifeSciences Holdings